Acquisition Alert Diplomat Pharmacy was acquired by UnitedHealth Group in December 2019 after signaling doubts about staying in business, indicating a potential shift in strategic priorities and partnership opportunities with insurers, PBMs, and specialty pharmacies.

Debt & Growth Historically funded with a substantial $800 million debt facility tied to a major acquisition, suggesting strong investor appetite and potential for future capital-backed expansion or partnerships in specialty pharmacy services.

PBM Synergy Diplomat has a focused pharmacy benefit management capability and has hired a senior executive for PBM finance, presenting opportunities to cross-sell PBM services, integrated tech platforms, and adherence solutions to payers and providers.

Adherence Tech Past initiatives include the Nomi medication adherence system and partnerships to deploy adherence technology, indicating a receptiveness to digital adherence tools that can be offered to insurers, providers, and employers.

Market Position With revenue in the mid hundreds of millions and connections to large players through acquisitions and partnerships, there is potential to target collaborators in the specialty pharma supply chain, including payers, distributors, and health systems seeking specialized fulfillment and integrated PBM capabilities.